|
|
Radiomics in the diagnosis and treatment of hepatocellular carcinoma |
Chun Jiang a , # , Yi-Qi Cai b , # , Jia-Jia Yang c , # , Can-Yu Ma b , Jia-Xi Chen b , Lan Huang a , Ze Xiang b , Jian Wu a , ∗ |
a Department of Clinical Laboratory, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou 215008, China
b Zhejiang University School of Medicine, Hangzhou 310030, China
c Department of Infection Management, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou 215008, China
∗Corresponding author.
E-mail address: wujianglinxing@163.com (J. Wu).
# Contributed equally. |
|
|
Abstract Hepatocellular carcinoma (HCC) is a common malignant tumor. At present, early diagnosis of HCC is difficult and therapeutic methods are limited. Radiomics can achieve accurate quantitative evaluation of the lesions without invasion, and has important value in the diagnosis and treatment of HCC. Radiomics features can predict the development of cancer in patients, serve as the basis for risk stratification of HCC patients, and help clinicians distinguish similar diseases, thus improving the diagnostic accuracy. Furthermore, the prediction of the treatment outcomes helps determine the treatment plan. Radiomics is also helpful in predicting the HCC recurrence, disease-free survival and overall survival. This review summa- rized the role of radiomics in the diagnosis, treatment and prognosis of HCC.
|
|
|
|
|
|
|
|